跳至主要内容
临床试验/CTRI/2018/08/015245
CTRI/2018/08/015245尚未招募不适用

Study Of Role Of Oral Zinc Supplement In Neonatal Hyperbilirubinemia.

Tejas Hukumchand Mandlecha1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2018年8月15日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
90
试验地点
1
主要终点
To Study Role Of Oral Zinc Sulphate Supplementation In Reduction Of Indirect Hyperbilirubinemia Term Neonate (more than 38 wk).

研究概览

简要总结

Zinc is one of the essential component in neonatal growth, protein synthesis and many other pathway. It has been shown to lower the serum Bilirubine level by inhibition of normal enterohepatic cycling of unconjugated bilirubin. Therefore, the anticipated role of oral zinc supplementation in neonatal jaundice seems to be attractive. This radamised clinical trial will be conducted on term neonate to characterize the role of zinc sulfate in neonatal hyperbilirubinemia.

研究设计

研究类型
Interventional
分配方式
Other
盲法
Open Label

入排标准

年龄范围
0.00 Day(s) 至 30.00 Day(s)(—)
性别
All

入选标准

  • All term neonate(>38wk) presented with indirect hyperbilirubinemia within phototherapy range.

排除标准

  • 1- Preterm neonate 2- neonates with DIRECT HYPERBILIRUBINEMIA 3 – neonate requiring EXCHAGE TRANSFUSION at any point of time during study 4.All cases with Sepsis at the time of enrollment, severe respiratory disease requiring mechanical ventilation, congenital anomalies 5-patient who refuses to continue are excluded from study.

结局指标

主要结局

To Study Role Of Oral Zinc Sulphate Supplementation In Reduction Of Indirect Hyperbilirubinemia Term Neonate (more than 38 wk).

时间窗: Use Of Zinc Till The Reduction Of Serum Bilirubine Below Phototherapy Range.

次要结局

  • 1.TO STUDY THE EFFECT OF ORAL ZINC SULPHATE IN EARLY DISCHARGE IN TERM NEONATE(38).(2.TO STUDY SIDE EFFECTS OF ZINC SUPPLEMENTATION)

研究者

发起方
Tejas Hukumchand Mandlecha
申办方类型
Other [individual]

研究点 (1)

Loading locations...

相似试验